Cardiac device innovations made waves in 2024, with regulatory approvals, clinical breakthroughs, and product launches ...

AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, ...

Medtronic (NYSE: MDT) today reported study results highlighting AFib detection with its Linq family of insertable cardiac monitors (ICM).

Results from the single-arm trial saw 63.5% of patients able to avoid the symptoms of Atrial fibrillation over the course of ...

Catheter Precision, Inc. (NYSE American:VTAK), a US based medical device company focused on developing technologically ...

Amy Paterson, Medical Analyst at GlobalData states, “Medtronic’s Sphere-9 launched at a lower price than Boston Scientific’s Farapulse originally did. It appears that Medtronic is intending to be ...

1.87% treatment). Atrial fibrillation burden decreased progressively ... Cardiac Rhythm Management Division, Sylmar, CA). Devices were programmed to DDDR pacing with a base rate of 60 bpm ...

Garmin (NYSE: GRMN) today announced the ECG App is now available to customers in Australia and the European Union with a ...

Looking back, Kokomo resident Mike Beatty knew he had something as a teenager, but he couldn’t put a name to it. Whenever he’d overexert himself, he’d feel “different,” but it would go away with rest.

CardioFocus, Inc., a medical device company dedicated to advancing ablation treatment for cardiac arrhythmias, today ...

FORT MILL, SOUTH CAROLINA / ACCESS Newswire / January 16, 2025 / Catheter Precision, Inc. (NYSE American:VTAK), a US based medical device company focused on developing technologically advanced product ...